Doctors at Samishta Hospital & Research Institute (SHRI), Guntur, cured a carbapenem-resistant artificial-knee infection with a three-phage cocktail — reported as India's first successful use of phage therapy for such an infection.
The 72-year-old patient's knee replacement (June 2025) was infected by Pseudomonas aeruginosa resistant to carbapenems and most strong antibiotics.
The phages were developed at Dr Sutharsan Govindarajan's laboratory at SRM University, Andhra Pradesh, and delivered into the joint over 10 days.
Six months after treatment (June 2026), joint-fluid culture showed no infection and the patient was antibiotic-free.
Bacteriophages are viruses that infect only bacteria. Lytic phages multiply inside a bacterial cell and burst it. Because most phages attack specific strains, the patient's isolate is matched to phages; cocktails of several phages slow the emergence of phage-resistant bacteria.
Simple Analogy: A guided missile locked to one enemy, instead of a bomb hitting everything.
Patient undergoes knee replacement surgery at Guntur
Artificial joint infected with carbapenem-resistant Pseudomonas aeruginosa
Three-phage cocktail delivered into the joint; colistin stopped on Day 6
No drug-resistant bacteria found in joint fluid
Six-month follow-up: joint-fluid culture negative; patient antibiotic-free
Case reported as India's first successful phage therapy for a carbapenem-resistant artificial-joint infection
Publishes the Bacterial Priority Pathogens List; the 2024 list has 24 pathogens across 15 families and places carbapenem-resistant Pseudomonas aeruginosa in the 'high' group (it was 'critical' in 2017)
Nodal ministry for India's National Action Plan on Antimicrobial Resistance
Five-year roadmap (2025-2029) to contain antimicrobial resistance under a One Health approach
Key: Launched on 18 November 2025, the first day of World AMR Awareness Week; succeeds the first NAP-AMR (2017-2021)
GS Paper III > Science and Technology > Biotechnology, health; AMR
General Science > Biology > Microorganisms
A virus that infects and replicates within bacteria
Broad-spectrum beta-lactam antibiotics (e.g., meropenem, imipenem) used as last-line drugs for serious infections
Infection of an artificial joint, often biofilm-forming and hard to clear with antibiotics